Remove Capital Remove Funding Remove Thousand Oaks
article thumbnail

Thousand Oaks Biopharmaceuticals Gets $45M In Series A For Biotech Manufacturing

socalTECH

Thousand Oaks- and Shanghai-based Thousand Oaks Biopharmaceuticals , a new contract manufacturing organization fort he biotech industry, said it has received $45M in a Series A financing round.

article thumbnail

Capsida Uncloaks With $140M In Funding

socalTECH

Thousand Oaks-based Capsida Biotherapeutics, a new biotechnology company focused on using adeno-associated virus (AAV) engineering and cargo development platform to develop tissue-targeted gene therapies for multiple types of diseases, has uncloaked from stealth mode, saying it has raised $140M in total capital.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Amgen Ventures Backs Akili In $55M Funding

socalTECH

Amgen Ventures , the venture capital arm of Thousand Oaks-based Amgen , is one of the investors in a Boston biotech company, Akili Interactive. Akili is developing digital medicine products aimed at treating cognitive dysfunction, including ADHD, multiple sclerosis, and depression. READ MORE>>.

article thumbnail

Amgen Ventures Backs Syapse In $30M Precision Oncology Funding

socalTECH

Amgen Ventures , the venture investment arm of Thousand Oaks-based Amgen , is one of the new investors in precision oncology and medicine startup Syapse. READ MORE>>.

article thumbnail

Amgen Backs Tizona Therapeutics In $43M Funding

socalTECH

Thousand Oaks-based Amgen has made another investment this morning in immunology startup Tizona Therapeutics , via its venture capital arm, Amgen Ventures. Series A investors--including Amgen Ventures--also participated, with investments from MPM Capital, Astellas Venture Management and InterWest Partners. READ MORE>>.

article thumbnail

Dantari Gets $47M For Tumor Medicine Effort

socalTECH

Thousand Oaks-based Dantari has raised $47M in its Series A funding, saying that it has launched a new, clinical-stage biotechnology company developing targeted therapeutics for the treatment of cancers and other diseases.

article thumbnail

Amgen Backs New $315M Life Sciences Fund

socalTECH

Thousand Oaks-based Amgen has helped to back a new, life sciences fund, managed by San Francisco-based venBio , as an anchor supporter of a new fund. venBio did not say how much Amgen committed to the fund, which is venBio's second life sciences fund. READ MORE>>.